In collaboration with RMIT University, Snoretox is developing the world’s first injectable solution to treat obstructive sleep apnoea and other conditions involving low muscle tone.

Our game-changing technology is based on molecules of tetanus toxin, modified to ensure they work around the tetanus vaccine.

Just as Botox uses tiny amounts of botulinum toxin to relax muscles, our prototype therapeutic uses minute amounts of safe modified tetanus toxin to achieve the opposite effect – muscle toning.

Snoretox Ltd

Org chart

Teams

Offices